BIIB r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	1,947,499,999
Mar 31, 2026	1,981,800,000
Dec 31, 2025	1,954,700,000
Sep 30, 2025	2,128,900,000
Jun 30, 2025	2,432,300,000
Mar 31, 2025	2,494,700,000
Dec 31, 2024	2,472,500,000
Sep 30, 2024	2,436,500,000
Jun 30, 2024	2,560,700,000
Mar 31, 2024	2,605,500,000
Dec 31, 2023	2,702,600,000
Sep 30, 2023	2,831,700,000
Jun 30, 2023	2,640,200,000
Mar 31, 2023	2,599,200,000
Dec 31, 2022	2,597,000,000
Sep 30, 2022	2,588,000,000
Jun 30, 2022	2,795,700,000
Mar 31, 2022	3,406,800,000
Dec 31, 2021	3,400,500,000
Sep 30, 2021	4,608,200,000
Jun 30, 2021	5,018,300,000
Mar 31, 2021	4,520,200,000
Dec 31, 2020	4,530,700,000
Sep 30, 2020	3,247,100,000
Jun 30, 2020	2,564,000,000
Mar 31, 2020	2,339,700,000
Dec 31, 2019	2,280,600,000
Sep 30, 2019	2,200,500,000
Jun 30, 2019	2,195,500,000
Mar 31, 2019	2,766,700,000
Dec 31, 2018	2,709,700,000
Sep 30, 2018	2,685,700,000
Jun 30, 2018	2,596,700,000
Mar 31, 2018	2,456,900,000
Dec 31, 2017	2,373,600,000
Sep 30, 2017	2,319,900,000
Jun 30, 2017	2,402,500,000
Mar 31, 2017	1,959,400,000
Dec 31, 2016	1,973,300,000
Sep 30, 2016	1,981,100,000
Jun 30, 2016	1,972,000,000
Mar 31, 2016	1,989,600,000
Dec 31, 2015	2,012,800,000
Sep 30, 2015	1,971,169,000
Jun 30, 2015	1,868,443,000
Mar 31, 2015	1,825,016,000
Dec 31, 2014	1,893,400,000
Sep 30, 2014	1,827,264,000
Jun 30, 2014	1,820,107,000
Mar 31, 2014	1,700,297,000
Dec 31, 2013	1,455,753,000
Sep 30, 2013	1,410,701,000
Jun 30, 2013	1,304,901,000
Mar 31, 2013	1,306,997,000
Dec 31, 2012	1,378,619,000
Sep 30, 2012	1,328,672,000
Jun 30, 2012	1,325,846,000
Mar 31, 2012	1,281,931,000
Dec 31, 2011	1,219,602,000
Sep 30, 2011	926,537,000
Jun 30, 2011	1,149,200,000
Mar 31, 2011	1,195,231,000
Dec 31, 2010	1,248,604,000
Sep 30, 2010	1,485,817,000
Jun 30, 2010	1,265,818,000
Mar 31, 2010	1,350,596,000
Dec 31, 2009	1,283,068,000
Sep 30, 2009	1,292,753,000
Jun 30, 2009	1,257,498,000
Mar 31, 2009	1,093,304,000
Dec 31, 2008	1,072,058,000
Sep 30, 2008	1,008,583,000
Jun 30, 2008	1,026,057,000
Mar 31, 2008	991,947,000
Dec 31, 2007	925,164,000
Sep 30, 2007	1,225,872,000
Jun 30, 2007	1,150,631,000
Mar 31, 2007	1,094,467,000
Dec 31, 2006	1,048,910,000
Sep 30, 2006	687,224,000
Jun 30, 2006	703,230,000
Mar 31, 2006	721,088,000
Dec 31, 2005	747,673,000
Sep 30, 2005	768,803,000
Jun 30, 2005	710,071,000
Mar 31, 2005	700,010,000
Dec 31, 2004	686,453,000
Sep 30, 2004	1,227,723,000
Jun 30, 2004	1,098,749,000
Mar 31, 2004	979,108,000
Dec 31, 2003	852,098,000
Sep 30, 2003	212,585,000
Jun 30, 2003	277,803,000
Mar 31, 2003	317,010,000
Dec 31, 2002	367,567,000
Sep 30, 2002	360,139,000
Jun 30, 2002	334,483,000
Mar 31, 2002	324,253,000
Dec 31, 2001	314,556,000
Sep 30, 2001	304,418,000